167 related articles for article (PubMed ID: 24037915)
1. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
Wen X; Liu H; Yu K; Liu Y
Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
[TBL] [Abstract][Full Text] [Related]
2. Questions about XY Wen et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".
Liu F; Zhang Q
Tumour Biol; 2015 Feb; 36(2):557-8. PubMed ID: 25663465
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: a meta-analysis.
Wang J; Cai Y
Tumour Biol; 2012 Dec; 33(6):1819-28. PubMed ID: 22718017
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.
Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W
Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472
[TBL] [Abstract][Full Text] [Related]
5. Letter regarding Wen X.Y. et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".
Guo HB; Xiao T
Tumour Biol; 2014 May; 35(5):5053. PubMed ID: 24449508
[No Abstract] [Full Text] [Related]
6. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
Li H; Zhang K; Liu LH; Ouyang Y; Bu J; Guo HB; Xiao T
Tumour Biol; 2014 Jun; 35(6):5487-91. PubMed ID: 24577891
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta-analysis.
Liu Y; Wang Y; Teng Z; Chen J; Li Y; Chen Z; Li Z; Zhang Z
Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26239566
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.
Chen J; Sun MX; Hua YQ; Cai ZD
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1205-10. PubMed ID: 24682390
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis.
Shi M; Yu B; Gao H; Mu J; Ji C
Mol Biol Rep; 2013 Jan; 40(1):617-23. PubMed ID: 23184003
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of elevated ezrin in patients with osteosarcoma.
Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
[TBL] [Abstract][Full Text] [Related]
13. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
Zhuang Y; Wei M
Tumour Biol; 2014 Mar; 35(3):1745-9. PubMed ID: 24515658
[TBL] [Abstract][Full Text] [Related]
14. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of RB1 tumour suppressor gene alterations in the clinical outcome of human osteosarcoma: a meta-analysis.
Ren W; Gu G
Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26503016
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of microRNAs in osteosarcoma: A meta-analysis.
Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K
Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730
[TBL] [Abstract][Full Text] [Related]
17. The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.
Zhang W; Ren X; Qi L; Zhang C; Tu C; Li Z
BMC Cancer; 2021 Feb; 21(1):202. PubMed ID: 33639865
[TBL] [Abstract][Full Text] [Related]
18. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.
Jiao G; Ren T; Lu Q; Sun Y; Lou Z; Peng X; Liang W; Guo W
Tumour Biol; 2013 Oct; 34(5):2489-95. PubMed ID: 23857285
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies.
Zhou J; Liu T; Wang W
Medicine (Baltimore); 2018 Nov; 97(44):e13051. PubMed ID: 30383677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
